PTGS2 and cancer: For PTGS2 rs689466, sensitivity analyses indicated that inclusion of the independent study by Andersen et al. [8] was mainly responsible for our original results in which no associations were observed between gene polymorphism and the risk of cancer development among non-NSAID users.